Replies to Post #245406 onBiotech Values

Replies to #245406 on Biotech Values

02/08/23 6:24 PM

#245413 RE: DewDiligence #245406

ABT acquires CSII for $20/sh cash—a 50% premium to today’s closing price:

• Abbott will gain an innovative, complementary solution in treating vascular disease through CSI's leading atherectomy system, which prepares vessels for angioplasty or stenting to restore blood flow

• CSI's offering will support Abbott's ability to provide better care for patients with peripheral and coronary artery disease

The nominal deal value is $890M. Closing requires approval of CSII’s shareholders, but that’s a fait accompli.

The Medical Devices business segment is ABT’s largest, accounting for 37% of corporate sales in 4Q22 (#msg-171028943).

ABT’s 2023 financial guidance remains unchanged—see #msg-171028771 for details.

chantillylive

02/08/23 7:15 PM

#245416 RE: DewDiligence #245406

Thank you Dew.
I had RVNC as riskier than ENTA but was at least on the same page as you. Also saw ABT as the Costco or BRK.B of the
five. Fortunately, added to my RVNC position last year in the teens. TU.
Will reenter ENTA but cannot understand PFE's price action.
Thanks again.
cl
BNGO on your watch list?

vinmantoo

02/09/23 12:40 AM

#245424 RE: DewDiligence #245406

I_consider_all_five—(RVNC, ENTA, ABT, BMY, PFE)—to_be_buys at their current valuations, but there is a wide disparity in risk and upside potential:

I agree and bought some more RVNC. I have been thinking about buying PFE for a while but haven't pulled the trigger on that yet.

sab63090

02/09/23 5:52 AM

#245425 RE: DewDiligence #245406

Thanks, I do have trouble with $PFE (Bourla)...

DewDiligence

02/09/23 3:05 PM

#245441 RE: DewDiligence #245406

BMY -2.5% today—possible reason is that the CEO just sold $18M worth of stock—approximately half his holding—(the Form-4 filing hit the wires last night after the close):

https://www.sec.gov/Archives/edgar/data/14272/000001427223000044/xslF345X03/wf-form4_167590496019590.xml

It's hard to interpret a transaction of this size as non-bearish. I wonder if Giovanni Caforio is planning to retire in the next 12-18 months.